BRISTOL-MYERS SQUIBB CO (1BMY.MI) Stock Fundamental Analysis
BIT:1BMY • US1101221083
51.43 EUR
+0.41 (+0.8%)
Last: Feb 16, 2026, 07:00 PM
Taking everything into account, 1BMY scores 5 out of 10 in our fundamental rating. 1BMY was compared to 52 industry peers in the Pharmaceuticals industry. Both the profitability and the financial health of 1BMY get a neutral evaluation. Nothing too spectacular is happening here. 1BMY is valued quite cheap, but it does not seem to be growing. Finally 1BMY also has an excellent dividend rating.
1. Profitability
1.1 Basic Checks
- 1BMY had positive earnings in the past year.
- In the past year 1BMY had a positive cash flow from operations.
- 1BMY had positive earnings in 4 of the past 5 years.
- Of the past 5 years 1BMY 4 years had a positive operating cash flow.
1.2 Ratios
- 1BMY has a Return On Assets of 6.23%. This is comparable to the rest of the industry: 1BMY outperforms 51.92% of its industry peers.
- Looking at the Return On Equity, with a value of 32.55%, 1BMY is in the better half of the industry, outperforming 78.85% of the companies in the same industry.
- 1BMY has a Return On Invested Capital of 17.64%. This is in the better half of the industry: 1BMY outperforms 71.15% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.23% | ||
| ROE | 32.55% | ||
| ROIC | 17.64% |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- Looking at the Profit Margin, with a value of 12.57%, 1BMY is in line with its industry, outperforming 48.08% of the companies in the same industry.
- 1BMY's Profit Margin has improved in the last couple of years.
- With an excellent Operating Margin value of 33.51%, 1BMY belongs to the best of the industry, outperforming 80.77% of the companies in the same industry.
- 1BMY's Operating Margin has improved in the last couple of years.
- 1BMY's Gross Margin of 73.15% is in line compared to the rest of the industry. 1BMY outperforms 57.69% of its industry peers.
- 1BMY's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 33.51% | ||
| PM (TTM) | 12.57% | ||
| GM | 73.15% |
OM growth 3Y13.23%
OM growth 5Y20.59%
PM growth 3Y2.21%
PM growth 5YN/A
GM growth 3Y-2.43%
GM growth 5Y-0.33%
2. Health
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so 1BMY is creating value.
- 1BMY has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
- 1BMY has an Altman-Z score of 2.33. This is not the best score and indicates that 1BMY is in the grey zone with still only limited risk for bankruptcy at the moment.
- 1BMY has a Altman-Z score (2.33) which is comparable to the rest of the industry.
- 1BMY has a debt to FCF ratio of 3.20. This is a good value and a sign of high solvency as 1BMY would need 3.20 years to pay back of all of its debts.
- Looking at the Debt to FCF ratio, with a value of 3.20, 1BMY is in the better half of the industry, outperforming 65.38% of the companies in the same industry.
- A Debt/Equity ratio of 2.41 is on the high side and indicates that 1BMY has dependencies on debt financing.
- 1BMY has a worse Debt to Equity ratio (2.41) than 82.69% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.41 | ||
| Debt/FCF | 3.2 | ||
| Altman-Z | 2.33 |
ROIC/WACC2.06
WACC8.58%
2.3 Liquidity
- A Current Ratio of 1.27 indicates that 1BMY should not have too much problems paying its short term obligations.
- With a Current ratio value of 1.27, 1BMY is not doing good in the industry: 61.54% of the companies in the same industry are doing better.
- 1BMY has a Quick Ratio of 1.17. This is a normal value and indicates that 1BMY is financially healthy and should not expect problems in meeting its short term obligations.
- Looking at the Quick ratio, with a value of 1.17, 1BMY is in the better half of the industry, outperforming 67.31% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.27 | ||
| Quick Ratio | 1.17 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an impressive 439.47% over the past year.
- Measured over the past years, 1BMY shows a decrease in Earnings Per Share. The EPS has been decreasing by -0.92% on average per year.
- Looking at the last year, 1BMY shows a decrease in Revenue. The Revenue has decreased by -0.22% in the last year.
- 1BMY shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.54% yearly.
EPS 1Y (TTM)439.47%
EPS 3Y-7.62%
EPS 5Y-0.92%
EPS Q2Q%-24.55%
Revenue 1Y (TTM)-0.22%
Revenue growth 3Y1.45%
Revenue growth 5Y2.54%
Sales Q2Q%1.3%
3.2 Future
- 1BMY is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -4.54% yearly.
- The Revenue is expected to decrease by -5.61% on average over the next years.
EPS Next Y-1.05%
EPS Next 2Y-1.88%
EPS Next 3Y-3.16%
EPS Next 5Y-4.54%
Revenue Next Year-7.97%
Revenue Next 2Y-5.07%
Revenue Next 3Y-5.93%
Revenue Next 5Y-5.61%
3.3 Evolution
- The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
- With a Price/Earnings ratio of 9.91, the valuation of 1BMY can be described as very reasonable.
- 88.46% of the companies in the same industry are more expensive than 1BMY, based on the Price/Earnings ratio.
- The average S&P500 Price/Earnings ratio is at 27.09. 1BMY is valued rather cheaply when compared to this.
- The Price/Forward Earnings ratio is 10.01, which indicates a very decent valuation of 1BMY.
- 82.69% of the companies in the same industry are more expensive than 1BMY, based on the Price/Forward Earnings ratio.
- When comparing the Price/Forward Earnings ratio of 1BMY to the average of the S&P500 Index (27.98), we can say 1BMY is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.91 | ||
| Fwd PE | 10.01 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, 1BMY is valued cheaper than 90.38% of the companies in the same industry.
- Based on the Price/Free Cash Flow ratio, 1BMY is valued cheaper than 98.08% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 8.1 | ||
| EV/EBITDA | 7.4 |
4.3 Compensation for Growth
- The decent profitability rating of 1BMY may justify a higher PE ratio.
- 1BMY's earnings are expected to decrease with -3.16% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-1.88%
EPS Next 3Y-3.16%
5. Dividend
5.1 Amount
- 1BMY has a Yearly Dividend Yield of 4.21%, which is a nice return.
- 1BMY's Dividend Yield is rather good when compared to the industry average which is at 1.91. 1BMY pays more dividend than 86.54% of the companies in the same industry.
- Compared to an average S&P500 Dividend Yield of 1.85, 1BMY pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.21% |
5.2 History
- On average, the dividend of 1BMY grows each year by 11.67%, which is quite nice.
Dividend Growth(5Y)11.67%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
- 82.81% of the earnings are spent on dividend by 1BMY. This is not a sustainable payout ratio.
- 1BMY's earnings are declining while the Dividend Rate has been growing. This means the dividend growth is most likely not sustainable.
DP82.81%
EPS Next 2Y-1.88%
EPS Next 3Y-3.16%
BIT:1BMY (2/16/2026, 7:00:00 PM)
51.43
+0.41 (+0.8%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)02-05 2026-02-05/bmo
Earnings (Next)04-30 2026-04-30
Inst Owners81.87%
Inst Owner ChangeN/A
Ins Owners0.02%
Ins Owner ChangeN/A
Market Cap104.70B
Revenue(TTM)48.19B
Net Income(TTM)6.04B
Analysts70.59
Price Target48.75 (-5.21%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.21% |
Yearly Dividend2.04
Dividend Growth(5Y)11.67%
DP82.81%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)20.98%
Min EPS beat(2)6.92%
Max EPS beat(2)35.04%
EPS beat(4)4
Avg EPS beat(4)18.72%
Min EPS beat(4)6.92%
Max EPS beat(4)35.04%
EPS beat(8)8
Avg EPS beat(8)16.52%
EPS beat(12)11
Avg EPS beat(12)11.66%
EPS beat(16)15
Avg EPS beat(16)10.13%
Revenue beat(2)2
Avg Revenue beat(2)4.61%
Min Revenue beat(2)2.43%
Max Revenue beat(2)6.79%
Revenue beat(4)4
Avg Revenue beat(4)4.63%
Min Revenue beat(4)2.43%
Max Revenue beat(4)6.79%
Revenue beat(8)8
Avg Revenue beat(8)3.95%
Revenue beat(12)9
Avg Revenue beat(12)1.94%
Revenue beat(16)11
Avg Revenue beat(16)1.64%
PT rev (1m)7.65%
PT rev (3m)9.84%
EPS NQ rev (1m)-32.01%
EPS NQ rev (3m)-28.39%
EPS NY rev (1m)-0.15%
EPS NY rev (3m)0.01%
Revenue NQ rev (1m)0.27%
Revenue NQ rev (3m)2.25%
Revenue NY rev (1m)0.27%
Revenue NY rev (3m)1.64%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.91 | ||
| Fwd PE | 10.01 | ||
| P/S | 2.58 | ||
| P/FCF | 8.1 | ||
| P/OCF | 7.46 | ||
| P/B | 6.68 | ||
| P/tB | N/A | ||
| EV/EBITDA | 7.4 |
EPS(TTM)5.19
EY10.09%
EPS(NY)5.14
Fwd EY9.99%
FCF(TTM)6.35
FCFY12.34%
OCF(TTM)6.89
OCFY13.4%
SpS19.92
BVpS7.69
TBVpS-9.81
PEG (NY)N/A
PEG (5Y)N/A
Graham Number29.97
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.23% | ||
| ROE | 32.55% | ||
| ROCE | 23.41% | ||
| ROIC | 17.64% | ||
| ROICexc | 23.19% | ||
| ROICexgc | 118.19% | ||
| OM | 33.51% | ||
| PM (TTM) | 12.57% | ||
| GM | 73.15% | ||
| FCFM | 31.86% |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y13.23%
OM growth 5Y20.59%
PM growth 3Y2.21%
PM growth 5YN/A
GM growth 3Y-2.43%
GM growth 5Y-0.33%
F-Score6
Asset Turnover0.5
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.41 | ||
| Debt/FCF | 3.2 | ||
| Debt/EBITDA | 2.13 | ||
| Cap/Depr | 26.84% | ||
| Cap/Sales | 2.75% | ||
| Interest Coverage | 7.66 | ||
| Cash Conversion | 79.11% | ||
| Profit Quality | 253.39% | ||
| Current Ratio | 1.27 | ||
| Quick Ratio | 1.17 | ||
| Altman-Z | 2.33 |
F-Score6
WACC8.58%
ROIC/WACC2.06
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)439.47%
EPS 3Y-7.62%
EPS 5Y-0.92%
EPS Q2Q%-24.55%
EPS Next Y-1.05%
EPS Next 2Y-1.88%
EPS Next 3Y-3.16%
EPS Next 5Y-4.54%
Revenue 1Y (TTM)-0.22%
Revenue growth 3Y1.45%
Revenue growth 5Y2.54%
Sales Q2Q%1.3%
Revenue Next Year-7.97%
Revenue Next 2Y-5.07%
Revenue Next 3Y-5.93%
Revenue Next 5Y-5.61%
EBIT growth 1Y44.7%
EBIT growth 3Y14.87%
EBIT growth 5Y23.65%
EBIT Next Year13.96%
EBIT Next 3Y0.03%
EBIT Next 5Y-1.73%
FCF growth 1Y10.86%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y10.78%
OCF growth 3YN/A
OCF growth 5YN/A
BRISTOL-MYERS SQUIBB CO / 1BMY.MI FAQ
Can you provide the ChartMill fundamental rating for BRISTOL-MYERS SQUIBB CO?
ChartMill assigns a fundamental rating of 5 / 10 to 1BMY.MI.
Can you provide the valuation status for BRISTOL-MYERS SQUIBB CO?
ChartMill assigns a valuation rating of 7 / 10 to BRISTOL-MYERS SQUIBB CO (1BMY.MI). This can be considered as Undervalued.
Can you provide the profitability details for BRISTOL-MYERS SQUIBB CO?
BRISTOL-MYERS SQUIBB CO (1BMY.MI) has a profitability rating of 6 / 10.
Can you provide the financial health for 1BMY stock?
The financial health rating of BRISTOL-MYERS SQUIBB CO (1BMY.MI) is 4 / 10.
Is the dividend of BRISTOL-MYERS SQUIBB CO sustainable?
The dividend rating of BRISTOL-MYERS SQUIBB CO (1BMY.MI) is 7 / 10 and the dividend payout ratio is 82.81%.